Pseudomorphine (Morphinan Dimer · Forensic Reference · No Opioid Activity)
| Compound | Pseudomorphine (Dehydromorphine Dimer; 2,2′-Bimorphine; Oxydimorphine) |
| Class | Alkaloid — Morphinan (Oxidative dimer) |
| CAS | 125-24-6 |
| Molecular formula | C₃₄H₃₆N₂O₆ |
| Primary sources | Papaver somniferum — formed by oxidative dimerisation of morphine in crude opium or during processing |
| Plant part | Capsule latex (trace, artefactual) |
| Claim strength | Emerging |
| Key applications | Forensic chemistry; opium processing artefact reference; informational-only |
| Buy from Herbuno | Informational reference — see HerbIQ Compound Index → |
Name origin: Pseudomorphine ("false morphine") was named because it was initially detected in opium and briefly considered a distinct plant alkaloid, before being recognised as an oxidative dimerisation product of morphine — two morphine molecules coupled via oxidative C-C bond formation at C-2. It is also called 2,2′-bimorphine or oxydimorphine in more systematic nomenclature. Traditional use: None — pseudomorphine is a chemical artefact rather than a biosynthetically programmed natural product. It forms from morphine under oxidative conditions during opium drying, storage, or alkaloid extraction processing. Its presence in opium preparations is inversely related to processing quality and freshness. Research trajectory: Pseudomorphine is most relevant to forensic alkaloid analysis and pharmaceutical quality control. Unlike morphine, it has no significant opioid activity — the dimeric structure prevents the receptor-binding geometry required for mu-opioid agonism. Research interest is primarily in its formation kinetics and as a stability marker for morphine-containing pharmaceutical preparations. Safety context: Pseudomorphine has no significant pharmacological activity and no abuse potential. It is present in aged or oxidised opium preparations and is removed in pharmaceutical morphine purification. Its toxicological profile is poorly characterised but irrelevant to any practical exposure scenario.
Pharmacological and Chemical Profile of Pseudomorphine
Absence of opioid activity: The 2,2′-bimorphine structure of pseudomorphine creates a symmetric dimer that cannot adopt the receptor-binding conformation required for mu-opioid agonism. In animal and receptor binding studies, pseudomorphine is essentially inactive at opioid receptors. This is the key pharmacological distinction from all other morphinan alkaloids. Claim strength: Moderate (preclinical).
Oxidative dimerisation chemistry: Morphine's C-2 position is susceptible to single-electron oxidation by metal ions (Fe³⁺, Cu²⁺), horseradish peroxidase, or manganese peroxidase — forming a radical that dimerises to pseudomorphine. This reaction is relevant to pharmaceutical stability: morphine solutions and injectable preparations can generate pseudomorphine under oxidative stress, detected by HPLC as an impurity peak. Claim strength: Moderate (analytical chemistry).
Forensic chemistry marker: The ratio of pseudomorphine to morphine in crude opium extracts reflects storage conditions and processing history. High pseudomorphine content indicates oxidative degradation during storage, poorly controlled drying, or adulteration. This makes it a useful authenticity and quality marker in opium forensic analysis. Claim strength: Moderate (analytical chemistry).
Historical misidentification: Before modern structural methods, pseudomorphine was catalogued as a discrete plant alkaloid ("dehydromorphine") and assigned pharmacological properties that were later found to be due to morphine contamination of impure pseudomorphine preparations. This historical confusion is documented in alkaloid chemistry literature as a cautionary example of artefact alkaloids. Claim strength: Moderate (historical/chemical).
This compound is documented for research and formulator education purposes. For commercially available botanical ingredients, explore the HerbIQ Compound Index →
Regulatory and Formulator Context
Pseudomorphine derives from Papaver somniferum morphine and falls within opiate regulatory frameworks by analogy in most jurisdictions, despite having no opioid activity itself. It is not a useful pharmaceutical or supplement compound.
Its practical relevance to formulators is minimal — it may appear as an HPLC impurity peak in morphine or crude opium alkaloid reference standards, requiring identification. Pharmaceutical-grade morphine preparations include pseudomorphine limits in quality specifications.
No supplement, cosmetic, or food application exists or is being explored for pseudomorphine. This entry serves as documentation of the full Papaver alkaloid artefact chemistry relevant to understanding pharmaceutical morphine processing.
The HerbIQ index documents pseudomorphine as part of its commitment to comprehensive Papaver alkaloid coverage, including processing artefacts and metabolites relevant to pharmaceutical chemistry and forensic science.
Frequently Asked Questions — Pseudomorphine
Is pseudomorphine a natural constituent of the opium poppy?
Pseudomorphine is not a biosynthetically programmed natural product of Papaver somniferum — it is an artefact formed by oxidative dimerisation of morphine during opium processing, drying, or storage. Fresh latex contains negligible pseudomorphine; aged, oxidised, or poorly processed opium contains more. It is classified as an artefact alkaloid rather than a true plant secondary metabolite.
Does pseudomorphine have any opioid activity?
No. The dimeric structure of pseudomorphine (two morphine units coupled at C-2) prevents adoption of the required receptor-binding conformation for mu-opioid agonism. Pseudomorphine is pharmacologically inactive at opioid receptors, distinguishing it from all monomeric morphinan alkaloids. This is why it does not contribute to the pharmacological effects of opium preparations.
How is pseudomorphine detected in pharmaceutical quality control?
Pseudomorphine is detected by reversed-phase HPLC with UV detection at 280 nm in morphine sulfate pharmaceutical preparations. European Pharmacopoeia and British Pharmacopoeia monographs for morphine include pseudomorphine as a specified impurity with limits (typically ≤0.1%). Oxidative stress testing accelerates its formation and is used to assess morphine product stability.
Why does pseudomorphine appear in opium forensic databases?
Forensic opium databases include pseudomorphine as part of comprehensive alkaloid fingerprinting. Its presence and ratio to morphine provide information on opium processing age and handling conditions, contributing to geographic origin analysis and supply chain tracing in drug enforcement chemistry.
Related compounds: Laudanosine, Reticuline, Porphyroxine, Morphine
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery